CPH:COLO-B

Coloplast Stock

DENMARK |CO |DKK

Price
kr1,075.50
Change
-1.38%
Today's Range
kr1,075.50 - kr1,101.50
52-Week Range
kr855.20 - kr1,187.00
Market Cap
kr228.78B
Volume
337.61K

About Coloplast (CPH:COLO-B)

(CPH:COLO-B) Coloplast A/S develops and markets intimate healthcare products and services worldwide. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as SpeediCath catheters that offer catheterization for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. In addition, it provides wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Show more

COLO-B Stock Price

Statistics Highlights (CPH:COLO-B)

Shares Outstanding 194.72M Beta 0.07
Public Float 130.38M P/E Ratio 50.28
% Short of Float - Dividend (Yield) 18.00 (0.02%)
Held by Insiders 35.80% Ex-Dividend Date May 10, 2021
Held by Institutions 21.52% IPO Date -

COLO-B Financial Summary

|
Sep 20 Sep 19 Sep 18
Revenue kr18.54B kr17.94B kr16.45B
EBITDA kr6.35B kr5.68B kr5.65B
Net Income kr4.20B kr3.87B kr3.85B
Total Assets kr13.50B kr12.73B kr11.77B
Total Cash kr323.00M kr356.00M kr297.00M
Total Debt kr kr kr
Jun 21 Mar 21 Dec 20
Revenue kr4.83B kr4.75B kr4.74B
EBITDA kr1.84B kr1.77B kr1.70B
Net Income kr1.25B kr1.13B kr1.14B
Total Assets kr15.46B kr15.25B kr14.93B
Total Cash kr447.00M kr418.00M kr435.00M
Total Debt kr kr kr

COLO-B Stock Price History

Coloplast Annual Stock Price History

Year Open Close Change
2021 kr940.80 kr1075.50 14.32%
2020 kr829.60 kr940.80 13.40%

Coloplast Daily Stock Price History

Date Open High Low Close Change Volume
Sep 17, 2021 kr1092.50 kr1101.50 kr1075.50 kr1075.50 -1.38% 337.61K
Sep 16, 2021 kr1093.00 kr1104.50 kr1090.50 kr1090.50 -0.27% 132.08K

(CPH:COLO-B) Stock Price FAQs

What is today's stock price of Coloplast (CPH:COLO-B)?

  • The current stock price of Coloplast (CPH:COLO-B) is kr1075.50.
  • Today COLO-B stock price opened at kr1092.50 after previous close of kr1090.50.
  • During the day, Coloplast stock quote has varied from a low of kr1075.50 to a high of kr1101.50.

What is Coloplast's 52-week change?

  • COLO-B 52-week high stock quote is kr1187.00, which is 10.40% above the current share price.
  • The Coloplast (CPH:COLO-B) 52-week low stock price is kr855.20, which is 20.50% below the current share price.
  • Coloplast share price volatility (52-week beta) is 0.07.

Coloplast (CPH:COLO-B) FAQ

How Much is Coloplast Worth?

Coloplast's worth today based on market capitalisation is kr228.78B

How much money does Coloplast make?

Last quarter (ended on June 30 ,2021) Coloplast generated a net income of kr1.25B, representing a 20.49% decrease compared to the same quarter a year before (ended on June 30 ,2020).
Last fiscal year (ended on September 30 ,2020) Coloplast generated a net income of kr4.20B, representing a 8.37% increase compare to the previous fiscal year (ended on September 30 ,2019).
View More Details on Coloplast's “Financials” Section

How much dividend does Coloplast Pay?

The current annualized dividend payout for COLO-B stock is kr18.00, the dividend yield is 1.65% and the payout ratio is 84.15%.
View More Details on Coloplast's "Dividend" Section

What were Coloplast’s last Earnings results?

For the last quarterly earnings period (ended on June 30, 2021) COLO-B reported kr5.88 EPS for the quarter.
View More Details on Coloplast's 'Earnings' Section

What is Coloplast’s Price to Earning (PE) ratio?

Coloplast has a Price to Earning (P/E) ratio of 50.28. COLO-B stock also has a Price to Sales (P/S) ratio of 12.09, a Price to Book of 33.49 and Price/Earnings to Growth (PEG) of 4.10.

What is the Coloplast's ticker?

Coloplast trades on the Copenhagen stock market in Denmark under the ticker symbol "COLO-B". Coloplast’s stock symbol can also be displayed as "CPH:COLO-B".

Who are the owners of Coloplast?

Coloplast (CPH:COLO-B) is owned by 21.52% institutional shareholders and by 35.80% insiders. The rest is owned by the public.
Explore More Details on Coloplast's “Ownership” Section

Who are the key executives of Coloplast (COLO-B)?

Coloplast's key executive team includes the following managers:

  • Mr. Kristian Villumsen, Pres & CEO (1970)
  • Mr. Anders Lonning-Skovgaard, Exec. VP & CFO (1972)
  • Mr. Allan Rasmussen, Exec. VP of Global Operations (1967)
  • Mr. Paul Marcun, Exec. VP of Growth (1967)
  • Mr. Thomas Barfod, Sr. Controller & Director (1970)
  • Ellen Bjurgert, VP of Investor Relations (NA)
  • Dennis Kaysen, Director of Corp. Communications (NA)
  • Ms. Camilla G. Mohl, Sr. VP of People & Culture (NA)
  • Mr. Nicolai Buhl Andersen, Exec. VP of Innovation (NA)
  • Mr. Alain Morvan, Sr. VP of Sales Europe (NA)

What is Coloplast’s Sector & Industry Classification?

Coloplast (CPH:COLO-B) is classified under the "Healthcare" sector and under the "Medical Instruments & Supplies" industry.

What is the ESG rating for Coloplast (CPH:COLO-B) ?

ESG scores assess the degree to which a company’s enterprise business value is at risk driven by environmental, social, and governance issues. The scores are a measure of risk on an absolute scale of 0-100, with a lower score meaning less risk.

COLO-B’s total ESG score is 9.69. The company’s environmental score is 1.03, social score is 2.18 and governance score is 3.48.
Coloplast (CPH:COLO-B) is involved in the following activities (which decreases its ESG score) : "animalTesting".

How many employees work for Coloplast?

Currently the number of employees working for Coloplast is 12,500.

Where are Coloplast's Headquarters?

Coloplast (CPH:COLO-B) is headquartered in Denmark.

What are Coloplast's Address and Phone Number?

Coloplast’s mailing address is Holtedam 1-3, Humlebæk, Denmark, 3050.
The company’s phone number is 45 49 11 11 11.

What is the official website for Coloplast?

Coloplast’s official website is http://www.coloplast.com